Article Details
Retrieved on: 2022-12-21 03:51:13
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Gilead Sciences and Arcus Biosciences are testing therapies containing anti-TIGIT monoclonal antibody against the anti-PD-1 zimberelimab.
Article found on: www.geneonline.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here